Literature DB >> 15842343

Discovery of alpha2-plasmin inhibitor and its congenital deficiency.

N Aoki1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15842343     DOI: 10.1111/j.1538-7836.2004.01055.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  7 in total

Review 1.  Tissue-type plasminogen activator as a therapeutic target in stroke.

Authors:  Iordanis Gravanis; Stella E Tsirka
Journal:  Expert Opin Ther Targets       Date:  2008-02       Impact factor: 6.902

2.  Evaluation of Fibrinolytic Inhibitors: Alpha-2-Antiplasmin and Plasminogen Activator Inhibitor 1 in Patients with Obstructive Sleep Apnoea.

Authors:  Maciej Zakrzewski; Ewelina Zakrzewska; Paweł Kiciński; Sylwia Przybylska-Kuć; Andrzej Dybała; Wojciech Myśliński; Jolanta Pastryk; Tomasz Tomaszewski; Jerzy Mosiewicz
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

3.  Site-specific PEGylation of micro-plasmin for improved thrombolytic therapy through engineering enhanced resistance against serpin mediated inhibition.

Authors:  Navneet Kaur; Prakash Kumar Sinha; Girish Sahni
Journal:  PLoS One       Date:  2019-05-29       Impact factor: 3.240

4.  Plasmin inhibitor deficiency: A case report.

Authors:  Ouissal Aissaoui; Rachid Cherkab; Lahoucine Barrou
Journal:  Clin Case Rep       Date:  2020-01-07

5.  Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.

Authors:  Satish Singh; Sofiyan Saleem; Guy L Reed
Journal:  Front Cardiovasc Med       Date:  2020-12-23

6.  Therapeutic use of α2-antiplasmin as an antifibrinolytic and hemostatic agent in surgery and regenerative medicine.

Authors:  Jialu Liu; Ani Solanki; Michael J V White; Jeffrey A Hubbell; Priscilla S Briquez
Journal:  NPJ Regen Med       Date:  2022-06-30

Review 7.  Regulation of plasminogen activation on cell surfaces and fibrin.

Authors:  T Urano; F J Castellino; Y Suzuki
Journal:  J Thromb Haemost       Date:  2018-05-20       Impact factor: 5.824

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.